FDA and NIH, as well as academic and industry stakeholders, are pressing Congress to provide renewable funding to support research consortia developing new tools that can spur medical innovation. While the House Energy and Commerce Committee's 21st Century Cures Initiative has examined areas where FDA and CMS policies can be revamped, industry and academic researchers last week also called for lawmakers to prioritize funding of consortia that often involve federal agencies but have unstable funding. Consortia are neutral environments where...
You've followed a link to an article or document on InsideHealthPolicy.com.
There are two ways you can access this content.
Subscriber Login
If you are an InsideHealthPolicy.com subscriber, or you have an active trial subscription, please login here:
Take A Trial Subscription
If you haven't already had a trial subscription to InsideHealthPolicy.com, you can sign up for one right now. Just click on the link below to get started -- you'll get full access for one month, including access to our newsletters, Inside CMS and FDA Week, plus daily news updates by e-mail and much, much more.
Sign up for a trial subscription.